Lowering LDL cholesterol with margarine containing plant stanol/sterol esters: Is it still relevant in 2011?

Complementary Therapies in Medicine

Volumn 19, Issue 1, 2011, Pages 37-46

  Doggrell, Sheila Anne ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Cardiovascular disease; Cholesterol; Ezetimibe; Fibrates; LDL cholesterol; Lipid soluble nutrients; Niacin; Stanols; Statins; Sterols

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA CAROTENE; ALPHA TOCOPHEROL; BETA CAROTENE; BEZAFIBRATE; CAMPESTANOL; CERIVASTATIN; COLESTYRAMINE; EZETIMIBE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYCOPENE; MARGARINE; NICOTINIC ACID; PRAVASTATIN; SIMVASTATIN; SITOSTANOL ESTER; STANOL ESTER; STATIN; STEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VEGETABLE OIL; VITAMIN K GROUP;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET THERAPY; DRUG DOSE COMPARISON; DRUG MEGADOSE; FAMILIAL HYPERCHOLESTEROLEMIA; FOOD SAFETY; HEREDITY; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MYOPATHY; NONHUMAN; REVIEW; RHABDOMYOLYSIS; RISK REDUCTION; TOXICITY TESTING; VITAMIN BLOOD LEVEL;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS; FIBRIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE II; INTESTINAL DISEASES; LIPID METABOLISM, INBORN ERRORS; MARGARINE; MICRONUTRIENTS; NIACIN; PHYTOSTEROLS; SITOSTEROLS; TRIGLYCERIDES;

EID: 79551565536     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2010.12.004     Document Type: Review

References (72)

1. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of the high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
2. Thompson G.R., Grundy S.M. History and development of plant sterol and stanol esters for cholesterol-lowering purposes. American Journal of Cardiology 2005, 96 IA:3D-9D.
3. Lichtenstein A.H., Lichtenstein R.J. Stanol/sterol ester-containing foods and blood cholesterol levels-a statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition Physical Activity, and Metabolism of the American Heart Association. Circulation 2001, 103:1177-1178. for the American Heart Association Nutrition Committee.
4. Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005, 366:1267-1278.
5. Miettinen T.A., Puska P., Gylling H., Vanhanen H., Vartianen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. New England Journal of Medicine 1995, 333:1308-1312.
6. Gylling H., Miettinen T.A. Cholesterol reduction by different plant sterol mixtures with variable fat intake. Metabolism 1999, 48:575-580.
7. Hallikainen M.A., Sarkkinen E.S., Uusitupa M.I. Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemia men and women in a dose-dependent manner. Journal of Nutrition 2000, 130:767-776.
8. Homma Y., Ikeda I., Ishikawa T., Tateno M., Sugano M., Nakamura H. Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidised low-density lipoprotein by plant stanol ester-containing spread: a randomized, placebo-controlled trial. Nutrition 2003, 19:369-374.
9. Plat J., van Onselen E.N., van Heugten M.M., Mensink R.P. Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. European Journal of Clinical Nutrition 2000, 54:671-677.
10. Blair S.N., Capuzzi D.M., Gottlieb S.O., Nguyen T., Morgan J.M., Cater N.B. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol and the addition of plant stanol ester-containing spread to statin therapy. American Journal of Cardiology 2000, 86:46-52.
11. Gylling H., Puska P., Vartianen E., Miettinen T.A. Retinol, vitamin D, carotenes and alpha-tocopherol in serum of a moderately hypercholesterolemic population consuming sitostanol ester margarine. Atherosclerosis 1999, 145:279-285.
12. Hendriks H.F., Weststrate J.A., van Vliet Meijer G.W. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. European Journal of Clinical Nutrition 1999, 53:319-327.
13. Maki K.C., Davidson M.H., Umporowicz D.M., Schaefer E.J., Dicklin M.R., Ingram K.A., et al. Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet. American Journal of Clinical Nutrition 2001, 74:33-43.
14. Simons L.A. Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia. American Journal of Cardiology 2002, 90:737-740.
15. Christiansen L.I., Lähteenmäki, Mannelin M.R., Seppänen-Laakso T.E., Hiltunen R.V., Yliruusu J.K. Cholesterol-lowering effect of spreads enriched with microcrystalline plant sterols in hypercholesterolemic subjects. European Journal of Nutrition 2001, 40:66-73.
16. Nigon F., Serfaty-Lacrosnière C., Buecler I., Chauvois D., Neveu C., Giral P., et al. Plant sterol-enriched margarine lowers plasma LDL in hyperlipidemic subjects with low cholesterol intake: effect of fibrate treatment. Clinical Chemistry and Laboratory Medicine 2001, 39:634-640.
17. Baker V.A., Hepburn P.A., Kennedy S.J., Jones P.A., Lea L.J., Sumpter J.P., et al. Safety evaluation of phytosterol esters. Part 1. Assessment of oestrogenicity using a combination of in vivo and in vitro assays. Food and Chemical Toxicology 1999, 37:13-22.
18. Hepburn P.A., Horner S.A., Smith M. Safety evaluation of phytosterol esters. Part 2. Subchronic 90-day oral toxicity study on phytosterol esters-a novel functional food. Food and Chemical Toxicology 1999, 37:521-532.
19. Waalkens-Berendsen D.H., Wolterbeek A.P., Wijnands M.V., Richold M., Hepburn P.A. Safety evaluation of phytosterol esters. Part 3. Two-generation reproduction study in rats with phytosterol esters-a novel functional food. Food and Chemical Toxicology 1999, 37:683-696.
20. Wolfreys A.M., Hepburn P.A. Safety evaluation of phytosterol esters. Part 7. Assessment of mutagenic activity of phytosterols, phystosterol esters and the cholesterol derivative, 4-cholesten-3-one. Food and Chemical Toxicology 2002, 40:461-470.
21. Weststrate J.A., Ayesh R., Bauer-Plank C., Drewitt P.N. Safety evaluation of phytosterol esters. Part 4. Faecal concentration of bile acids and neutral sterols in healthy normolipidaemic volunteers consuming a controlled diet either with or without a phytosterol ester-enriched margarine. Food and Chemical Toxicology 1999, 37:1063-1071.
22. Ayesh R., Weststrate J.A., Drewitt P.N., Hepburn P.A. Safety evaluation of phytosterol esters. Part 5. Faecal short-chain fatty acid and microflora content, faecal bacterial enzyme activity and serum female sex hormones in healthy normolipidaemic volunteers consuming a controlled diet either with or without a phytosterol ester-enriched margarine. Food and Chemical Toxicology 1999, 37:1127-1138.
23. Hendriks H.F., Brink E.J., Meijer G.W., Princen H.M., Ntanios F.Y. Safety of long-term consumption of plant sterol esters-enriched spread. European Journal of Clinical Nutrition 2003, 57:681-692.
24. Jones P.J., Raeini-Sarjaz M., Ntanios F.Y., Vanstone C.A., Feng J.Y., Parsons W.E. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. Journal of Lipid Research 2000, 41:697-705.
25. Noakes M., Clifton P., Ntanios F., Shrapnel W., Record I., McInerney J. An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. American Journal of Clinical Nutrition 2002, 75:79-86.
26. De Jong A., Plat J., Bast A., Godschalk R.W., Basu S., Mensink R.P. Effects of plant sterol and stanol ester consumption of lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients with current statin treatment. European Journal of Clinical Nutrition 2008, 62:263-273.
27. De Jong A., Plant J., Lütjohann D., Mensink R.P. Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment. British Journal of Nutrition 2008, 100:937-941.
28. Plat P., Mensink R.P. Vegetable oil versus wood based stanol ester mixtures: effects on serum lipids and hemostatic factors in non-hypercholesterolemic subjects. Atherosclerosis 2000, 148:101-112.
29. Widhalm K. Pedriatic guidelines for lipid reduction. European Heart Journal 1987, 8(Suppl.):65-70.
30. Amundsen A.L., Ose L., Nenseter M.S., Ntanios F.Y. Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia. American Journal of Clinical Nutrition 2002, 76:338-344.
31. Amundsen A.L., Ntanios F., Put N., Ose L. Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread. European Journal of Clinical Nutrition 2004, 58:1612-1620.
32. Gylling H., Siimes M.A., Miettinen T.A. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia. Journal Lipid Research 1995, 36:1807-1812.
33. Stalenhoef A.F., Hectors M., Demacker P.N. Effect of plant sterol-enriched margarine on plasma lipids and sterols in subjects heterozygous for phytosterolaemia. Journal of Internal Medicine 2001, 249:163-166.
34. Kwiterovich P.O., Chen S.C., Virgil D.G., Schweitzer A., Arnold D.R., Kratz L.E. Response of obligate heterozygotes for phytosterolemia to a low-fat diet and to a plant sterol ester dietary challenge. Journal of Lipid Research 2003, 44:1143-1155.
35. Geelen A., Zock P.L., de Vries J.H., Katan M.B. Apolipoprotein E polymorphism and serum lipid responses to plant sterols in humans. European Journal of Clinical Investigation 2002, 32:738-742.
36. Lottenberg A.M., Nunes V.S., Nakandakare E.R., Neves M., Bernik M., Lagrost L., et al. The human cholesteryl ester transfer protein 1405V polymorphism is associated with plasma cholesterol concentration and its reduction by dietary phytosterol esters. Journal of Nutrition 2003, 133:1800-1805.
37. Tammi A., Rönnemaa T., Miettinen T.A., Gylling H., Rask-Nissilä L., Viikari J., et al. Effects of gender, apolipoprotein E phenotype and cholesterol lowering by plant stanol esters in children: the STRIP study Special Turku Coronary Risk Factor Intervention Project. Acta Paediatrica 2002, 91:1155-1162.
38. Hallikainen M., Lyyra-Laitinen T., Laitinen T., Moilanen, Miettinen T.A., Gylling H. Effects of plant stanol esters on serum cholesterol concentrations, relative markers of cholesterol metabolism and endothelial function in type 1 diabetes. Atherosclerosis 2008, 199:432-439.
39. Gylling H., Miettinen T.A. Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia 1994, 37:773-780.
40. Lee Y.M., Haastert B., Scherbaum W., Hauner H. A phytosterol-enriched spread improves the lipid profile of subjects with type 2 diabetes mellitus-a randomized controlled trial under free-living conditions. European Journal of Nutrition 2003, 42:111-117.
41. Gylling H., Miettinen T.A. Effect of inhibiting cholesterol absorption and synthesis on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin-dependent diabetic men. Journal of Lipid Research 1996, 37:1776-1785.
42. Gylling H., Radhakrishnan R., Miettinen T.A. Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: women and dietary sitostanol. Circulation 1997, 96:4226-4231.
43. Gylling H., Miettinen T.A. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects. Nutrition Metabolism and Cardiovascular Diseases 2002, 12:19-23.
44. Benecol. [accessed 29/3/2010]. http://www.benecol.net/hls.asp%3FviewID=2818.
45. Wolfs M., de Jong N., Ocké M.C., Verhagen H., Verschuren W.M.M. Effectiveness of customary use of phytosterol/-stanol enriched margarines on blood cholesterol lowering. Food and Chemical Toxicology 2006, 44:1682-1688.
46. De Jong N., Zuur A., Wolfs M.C., Wendel-Vos G.C., van Raaij J.M., Schuit A.J. Exposure and effectiveness of phytosterol/-stanol-enriched margarines. European Journal of Clinical Nutrition 2007, 61:1407-1415.
47. Gagne C., Gaudet D., Bruckert E., Ezetimibe Study Group Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation 2002, 105:2469-2475.
48. Lütjohann D., von Bergmann K., Macdonell S.W., Johnson-Levonas A.O., Shah A., Lin J., Sapre A., Musliner T. Long-term efficacy and safety of ezetimibe 10mg in patients with homozygous sitosterolemia: a 2-year, open-label extension study. International Journal of Clinical Practice 2008, 62:1499-1510.
49. Calpe-Berdiel L., Méndez-González J., Blanco-Vaca F., Escolá-Gil J.C. Increased plasma levels of plant sterols and atherosclerosis: a controversial issue. Current Atherosclerosis Reports 2009, 11:391-398.
50. Gey K.F., Moser U.K., Jordan P., Stahelin H.B., Eichholzer M., Ludin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. American Journal of Clinical Nutrition 1993, 57(5 Suppl.):287S-297S.
51. Hennekens C.H., Buring J.E., Manson J.E., Stampfer M., Rosner B., Cook N.R., Belanger C., LaMotte F., Gaziano J.M., Ridker P.M., Willett W., Peto R. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. New England Journal of Medicine 1996, 334:1145-1149.
52. Colgan H.A., Floyd S., Noone E.J., Gibney M.J., Roche H.M. Increased intake of fruit and vegetables and a low-fat diet, with and without low-fat plant sterol-enriched spread consumption: effects on plasma lipoprotein and carotenoid metabolism. Journal of Human Nutrition and Dietetics 2004, 17:561-569.
53. Law M.R, Wald N.J., Thompson S.G. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischemic heart disease?. BMJ 1994, 308:367-373.
54. Law M. Plant sterol and stanol margarines and health. BMJ 2000, 320:861-863.
55. Chirovsky D.R., Fedirko V., Cui Y., Sazonov V., Barter P. Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review. European Journal of Cardiovascular Prevention and Rehabilitation 2009, 16:404-423.
56. Morrison A., Hokanson J.E. The independent relationship between triglycerides and coronary heart disease. Vascular Health and Risk Management 2009, 5:89-95.
57. Clifton P.M., Mano M., Duchateau G.S., van der Knaap H.C., Tautwein E.A. Dose-response effects of different plant sterol sources in fat spreads on serum lipids and C-reactive protein and on the kinetic behavior of serum plant sterols. European Journal of Clinical Nutrition 2008, 62:968-977.
58. Masumoto A., Hirooka Y., Hironaga K., Eshima K., Setoguchi K., Takeshita A. Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin). American Journal of Cardiology 2001, 88:1291-1294.
59. Raitakari O.T., Salo P., Gylling H., Miettinen T.A. Plant stanol ester consumption and arterial elasticity and endothelial function. British Journal of Nutrition 2008, 100:603-608.
60. de Jongh S., Lillen M.R., op't Roodt J., Stroes E.S., Bakker H.D., Kastelein J.J. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. Journal of the American College of Cardiology 2002, 40:2117-2121.
61. de Jongh S., Vissers M.N., Rol P., Bakker H.D., Kastelein J.J., Stroes E.S. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolemia. Journal of Inherited Metabolic Disease 2003, 26:343-351.
62. Cannon C.P., Steinberg B.A., Murphy S.A., Mega J.L., Braunwald E. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. Journal of the American College of Cardiology 2006, 48:438-445.
63. Armitage J. The safety of statins in clinical practice. Lancet 2007, 370:1781-1790.
64. Al Badarin F.J., Kullo I.J., Kopecky S.L., Thomas R.J. Impact of ezetimibe on atherosclerosis: is the jury still out?. Mayo Clinical Proceedings 2009, 84:353-361.
65. Pisciotta L., Fasano T., Bellochhio A., Bocchi L., Sallo R., Fresa R., et al. Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients. Atherosclerosis 2007, 194:e116-e122.
66. Denke M., Pearson T., McBride P., Gazzara R.A., Brady W.E., Tershakovec A.M. Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome. Diabetes and Vascular Disease Research 2006, 3:93-102.
67. Salen G., von Bergmann K., Lütjohann D., Kwiterivich P., Kane J., Patel S.B., et al. Ezetimibe effectively reduced plasma plant sterols in patients with sitosterolemia. Circulation 2004, 109:966-971.
68. Guyton J.R. Effect on niacin on atherosclerotic cardiovascular disease. American Journal of Cardiology 1998, 82:18U-41U.
69. Taylor A.J., Villines T.C., Stanek E.J., Devine P.J., Griffen L., Miller M., Weissman N.J., Turco M. Extended-release niacin or ezetimibe and carotid intima-media thickness. New England Journal of Medicine 2009, 361:2113-2122.
70. St-Pierre A.C., Cantin B., Dagenais G.R., Mauriège P., Bernard P.-M., Després J.-P., et al. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men-13-year follow-up data from the Québec Cardiovascular Study. Arteriosclerosis. Thrombosis and Vascular Biology 2005, 25:553-559.
71. Ruotolo G., Ericsson C.G., Tettamanti C., Karpe F., Grip L., Svane B., et al. Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationship of lipoprotein variables in progression of coronary artery disease in Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT). Journal of the American College of Cardiology 1998, 32:1648-1656.
72. Varady K.A, St-Pierre A.C., Lamarche B., Jones P.J.H. Effect of plant sterols and endurance training on LDL particle size and distribution in previously sedentary hypercholesterolemic adults. European Journal of Clinical Nutrition 2005, 59:518-525.